CD27-Positive B-Cell Count Monitoring and Rituximab Dosing in Patients With NMOSD and MOGAD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology and Therapy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study
Neurol Ther 2023 May 11;[EPub Ahead of Print], N Bruschi, M Malentacchi, S Malucchi, F Sperli, S Martire, A Sala, P Valentino, A Bertolotto, M Pautasso, MA CapobiancoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.